# Avidity Biosciences, Inc. (RNA)

Novartis is acquiring Avidity Biosciences for $12 billion, a move that significantly bolsters its rare disease pipeline with Avidity's RNA-based therapies. This news has driven increased trading volume and positive sentiment.

### About Avidity Biosciences, Inc.
Avidity Biosciences, Inc. is a biopharmaceutical company focused on developing RNA-based therapeutics.  
Avidity Biosciences, Inc. uses the ticker $RNA for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Avidity Biosciences, Inc. (RNA) social dominance is up 245.71% from the previous week.
- Avidity Biosciences, Inc. (RNA) Galaxy Score™ is up 73.68% from the previous week.
- Avidity Biosciences, Inc. (RNA) sentiment is up 76% from the previous month.

### Price: $72.90
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$rna/time-series/close.tsv)  
The stock price is nearing its 52-week high, driven by the news of the Novartis acquisition which offers a significant premium, leading to increased trading volume and positive sentiment.  

24-Hour: -0.29%
7-Day: 0.02%
30-Day: 0.5%

1-Year High: $72.90 on 2026-02-03  
1-Year Low: $24.10 on 2025-04-08  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$rna/time-series/alt_rank.tsv)  
Avidity Biosciences, Inc. (RNA) is currently AltRank #1,561 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +621  
[--] Month: [-----] +425  
[--] Months: [-----] +1,162  
[--] Year: [-----] +809  
1-Year High: [-----] on 2025-03-16  
1-Year Low: [--] on 2025-08-10  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$rna/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +14  
[--] Month: [--] [---]  
[--] Months: [--] no change  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-09-24  
1-Year Low: [--] on 2025-04-13  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$rna/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] -39%  
[--] Month: [-------] -39%  
[--] Months: [---------] +77%  
[--] Year: [---------] +28%  
1-Year High: [-------] on 2025-10-26  
1-Year Low: [---] on 2025-06-15  

Engagements by network (24h):
TikTok: [--]
Reddit: [--]
X: [-----]
News: [--]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$rna/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [---]  
[--] Week: [---] no change  
[--] Month: [---] -3.60%  
[--] Months: [-----] +66%  
[--] Year: [-----] +23%  
1-Year High: [-----] on 2025-10-27  
1-Year Low: [--] on 2025-05-03  

Mentions by network (24h):
TikTok: [--]
Reddit: [--]
X: [--]
News: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$rna/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Avidity Biosciences, Inc. (RNA) in the last [--] hours which is down 6.30% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] -8%  
[--] Month: [---] -4.60%  
[--] Months: [-----] +46%  
[--] Year: [-----] +89%  
1-Year High: [---] on 2025-10-28  
1-Year Low: [--] on 2025-05-03  

The most influential creators that mention Avidity Biosciences, Inc. in the last [--] hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | [--]    | [-----]     | [--]     | [--]           |
| [@HedgeFundTips](/creator/twitter/HedgeFundTips) | [--]    | [------]    | [--]     | [--]           |
| [@seedy19tron](/creator/twitter/seedy19tron)     | [--]    | [------]    | [--]     | [--]           |
| [@Wartok262](/creator/twitter/Wartok262)         | [--]    | [--]         | [--]     | [--]           |

[View More](/list/creators/$rna/100)
  
  
### Sentiment: 75%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rna/time-series/sentiment.tsv)  
Current Value: 75%  
Daily Average: 80%  
[--] Week: 100% +22%  
[--] Month: 88% +38%  
[--] Months: 88% -2%  
[--] Year: 88% -1%  
1-Year High: 100% on 2025-02-21  
1-Year Low: 32% on 2025-12-06  

Most Supportive Themes:
- Novartis Acquisition: (80%) Novartis is acquiring Avidity Biosciences for $12 billion, significantly bolstering its rare disease pipeline with Avidity's RNA-based therapies.
- RNA Therapeutics Pipeline: (15%) Avidity's proprietary Antibody Oligonucleotide Conjugates (AOCs) platform and late-stage RNA therapies are key assets driving the acquisition.
  
Most Critical Themes:
- Clinical Holds and Discontinuations: (5%) Concerns exist regarding potential clinical holds and Discontinuations in related RNA therapies, which could impact future developments.
  
  
  
### Social Dominance: 0.00234%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$rna/time-series/social_dominance.tsv)  
Current Value: 0.00234%  
Daily Average: 0.016%  
[--] Week: 0.00242% +0.00172%  
[--] Month: 0.0031% -0.0043%  
[--] Months: 0.0031% -0.016%  
[--] Year: 0.0031% -0.014%  
1-Year High: 0.132% on 2025-10-27  
1-Year Low: 0.0027% on 2026-02-14  
  
  
### Market Dominance: 0.013%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$rna/time-series/market_dominance.tsv)  
Current Value: 0.013%  
Daily Average: 0%  
1-Year High: 0.133% on 2025-03-31  
1-Year Low: 0.00451% on 2025-06-30  
  
  
### Market Cap: $11,256,875,330
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$rna/time-series/market_cap.tsv)  
Current Value: $11,256,875,330  
Daily Average: $6,529,066,114  
[--] Week: $11,230,613,922 -0.27%  
[--] Month: $11,256,875,330 +3%  
[--] Months: $11,256,875,330 +99%  
[--] Year: $11,256,875,330 +192%  
1-Year High: $11,266,144,062 on 2026-02-03  
1-Year Low: $2,894,712,208 on 2025-04-08  

### Top Avidity Biosciences, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"If you followed me last year you know we hit a few biotech home runs like Lineage Cell Therapeutics ( $LCTX) UroGen Pharma ( $URGN) Avidity Biosciences ( $RNA) Teva Pharmaceutical Industries ( $TEVA) and more. That was thanks to our biotech expert who previously managed a $1B hedge fund and now shares his best ideas with us as a way of giving back to the community. Today were introducing what we believe could be the first home run of [----]. Massive CEO buying a near-perfect setup and multiple asymmetric catalysts ahead. Ill publish the full conversation later today. Hope it helps everyone."  
[X Link](https://x.com/ZeeContrarian1/status/2009228848341365035) [@ZeeContrarian1](/creator/x/ZeeContrarian1) 2026-01-08T11:41Z 36.8K followers, 106.1K engagements


"LT position into [----] Part [--] # [--] Portfolio Pick Buyouts $RNA $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP $ITCI $KVUE Tech positions in order- $AMZN $TSLA $SOFI $COIN $GOOG $NVDA $AMD $RBRK $META $NFLX $UBER $MSFT $AVGO $ZS $MELI $IREN $NBIS Top Biotech positions: $VKTX $CYTK $BBIO $TMDX $MDGL $HROW $SLNO $IMNM $GPCR $OCUL $CRVS https://twitter.com/i/web/status/2002067407834374356 https://twitter.com/i/web/status/2002067407834374356"  
[X Link](https://x.com/Pharmdca/status/2002067407834374356) [@Pharmdca](/creator/x/Pharmdca) 2025-12-19T17:24Z 108.6K followers, 56.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing